Product update

References

RELIZEN: NONHORMONAL TX FOR HOT FLASHESRELIZEN® is a patented, nonhormonal therapy for the relief of hot flashes associated with menopause from JDS Therapeutics.New to the United States, Relizen has been used by women and physicians in Europe for more than 15 years, according to the manufacturer, and has clinical efficacy data established in a placebo-controlled trial published in Climacteric. The active ingredient is a non-estrogenic, purified Swedish pollen extract that has pollen allergens removed. The daily dose is 2 pills/day.FOR MORE INFORMATION, VISIT www.relizen.com

RISK ASSESSMENT FOR SPORADIC BREAST CABREVAGenplus, from Phenogen Sciences, Inc, assesses clinical risk factors (Gail score) and genetic markers (SNP profile) to determine 5-year and lifetime risks of developing sporadic (nonhereditary) breast cancer. The test is for Caucasian, Hispanic, and African-American women, aged 35 years and older, who have not had breast cancer but have one or more risk factors for developing breast cancer.FOR MORE INFORMATION, VISIT http://phenogensciences.com

NONINVASIVE PRENATAL GENETIC BLOOD TESTSynapse Diagnostics offers Materni T21 PLUS, a test for specific chromosomal conditions in a fetus that are associated with birth defects. Conducted on blood drawn from the mother as early as 10 weeks’ gestation, the test uses genomic sequencing. Synapse Diagnostics claims that this is the only test that not only detects abnormalities like Down syndrome but also reveals defects called “microdeletions” caused by a missing gene that are otherwise difficult to discover early in pregnancy. FOR MORE INFORMATION, VISIT www.synapsediagnostics.com

NEW ULTRASOUND SYSTEMSamsung Electronics America, Inc. has introduced the UGEO WS80A ultrasound system for ObGyn applications. Key features: 21.5"-wide LED monitor with touch panel, 5D technologies, FRVtm (Feto Realistic View) with 3D visualization, and piezoelectric crystal design for high resolution. Samsung reports that the UGEO WS80A has improved gray scale and color with a more precise signal, speckle reduction, and edge and contrast enhancement. FOR MORE INFORMATION, VISIT www.samsung.com/healthcare

SEAL & CUT TECHNOLOGYAesculap has expanded its line of Caiman 5 Seal and Cut Technology to include 24-cm and 44-cm lengths of vessel sealing devices in addition to its original 36-cm device. Aesculap claims that the extended jaw design provides uniform pressure distribution across a variety of tissue thicknesses. These bipolar electrosurgical RF energy instruments are intended for open and laparoscopic surgery. FOR MORE INFORMATION, VISIT www.caimansurgery.com